Copyright Reports & Markets. All rights reserved.

Global NK Cell Therapy Industry Sales Market(Sales,Revenue and competitors Analysis of Major Market)from 2014-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Executive Summary

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 NK Cell Therapy Industry Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 NK Cell Therapies
      • 2.1.2 NK Cell Directed Antibodies
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 NK Cell Therapies
      • 2.2.2 NK Cell Directed Antibodies

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Cancer
      • 3.1.2 Gastrointestinal Diseases
      • 3.1.3 Others

    4 Manufacturers Profiles/Analysis

    • 4.1 Nektar Therapeutics
      • 4.1.1 Nektar Therapeutics Profiles
      • 4.1.2 Nektar Therapeutics Product Information
      • 4.1.3 Nektar Therapeutics NK Cell Therapy Industry Sales, Sales Value(Million USD), Price and Gross Profit
      • 4.1.4 Nektar Therapeutics SWOT Analysis
    • 4.2 Innate Pharma SA
      • 4.2.1 Innate Pharma SA Profiles
      • 4.2.2 Innate Pharma SA Product Information
      • 4.2.3 Innate Pharma SA NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.2.4 Innate Pharma SA SWOT Analysis
    • 4.3 Affimed
      • 4.3.1 Affimed Profiles
      • 4.3.2 Affimed Product Information
      • 4.3.3 Affimed NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.3.4 Affimed SWOT Analysis
    • 4.4 Chipscreen Biosciences
      • 4.4.1 Chipscreen Biosciences Profiles
      • 4.4.2 Chipscreen Biosciences Product Information
      • 4.4.3 Chipscreen Biosciences NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.4.4 Chipscreen Biosciences SWOT Analysis
    • 4.5 Fate Therapeutics
      • 4.5.1 Fate Therapeutics Profiles
      • 4.5.2 Fate Therapeutics Product Information
      • 4.5.3 Fate Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.5.4 Fate Therapeutics SWOT Analysis
    • 4.6 Glycostem Therapeutics
      • 4.6.1 Glycostem Therapeutics Profiles
      • 4.6.2 Glycostem Therapeutics Product Information
      • 4.6.3 Glycostem Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.6.4 Glycostem Therapeutics SWOT Analysis
    • 4.7 Dragonfly Therapeutics
      • 4.7.1 Dragonfly Therapeutics Profiles
      • 4.7.2 Dragonfly Therapeutics Product Information
      • 4.7.3 Dragonfly Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.7.4 Dragonfly Therapeutics SWOT Analysis
    • 4.8 Kiadis Pharma
      • 4.8.1 Kiadis Pharma Profiles
      • 4.8.2 Kiadis Pharma Product Information
      • 4.8.3 Kiadis Pharma NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.8.4 Kiadis Pharma SWOT Analysis
    • 4.9 NantWorks
      • 4.9.1 NantWorks Profiles
      • 4.9.2 NantWorks Product Information
      • 4.9.3 NantWorks NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.9.4 NantWorks SWOT Analysis
    • 4.10 Nkarta Therapeutics
      • 4.10.1 Nkarta Therapeutics Profiles
      • 4.10.2 Nkarta Therapeutics Product Information
      • 4.10.3 Nkarta Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
      • 4.10.4 Nkarta Therapeutics SWOT Analysis
    • 4.11 Fortress Biotech

    5 Market Performance for Manufacturers

    • 5.1 Global NK Cell Therapy Industry Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Global NK Cell Therapy Industry Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Global NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Global NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 China NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 China NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 China NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 USA NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 USA NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 USA NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 Europe NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 Europe NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 Europe NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Japan NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Japan NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Japan NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Korea NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Korea NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Korea NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 India NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 India NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 India NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Southeast Asia NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Southeast Asia NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Southeast Asia NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 South America NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 South America NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 South America NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Global NK Cell Therapy Industry Market Assessment by Regions (2014-2020)

    • 7.1 Global NK Cell Therapy Industry Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Global NK Cell Therapy Industry Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Global NK Cell Therapy Industry Price (USD/Unit) by Regions 2014-2020
    • 7.4 Global NK Cell Therapy Industry Gross Margin by Regions 2014-2020

    8 Development Trend for Regions

    • 8.1 Global NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.2 China NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.3 USA NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 Europe NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.5 Japan NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.6 Korea NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.7 India NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
    • 8.8 Southeast Asia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Manufacturing Plants Distribution

    11 Consumer Analysis

    • 11.1 Cancer Industry
    • 11.2 Gastrointestinal Diseases Industry
    • 11.3 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Global NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Global NK Cell Therapy Industry Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 China NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 USA NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 Europe NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Japan NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Korea NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 India NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Southeast Asia NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.10 South America NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 NK Cell Therapies
      • 12.2.3 NK Cell Directed Antibodies
    • 12.3 Sales (K Units) Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Cancer
      • 12.3.3 Gastrointestinal Diseases
      • 12.3.4 Others
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global NK Cell Therapy Industry Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Global NK Cell Therapy Industry Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, according to this study, over the next five years the NK Cell Therapy Industrymarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in NK Cell Therapy Industrybusiness.
    NK Cell Therapy Industry market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
    Sales forecast by type/application from 2021-2026
    Industry chain, downstream and upstream information is also included.

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of NK Cell Therapy Industry for these regions, from 2014 to 2026 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global NK Cell Therapy Industry market competition by top manufacturers/players, with NK Cell Therapy Industry sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Nektar Therapeutics
    Innate Pharma SA
    Affimed
    Chipscreen Biosciences
    Fate Therapeutics
    Glycostem Therapeutics
    Dragonfly Therapeutics
    Kiadis Pharma
    NantWorks
    Nkarta Therapeutics
    Fortress Biotech
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    NK Cell Therapies
    NK Cell Directed Antibodies
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of NK Cell Therapy Industry for each application, including
    Cancer
    Gastrointestinal Diseases
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now